Articles / institutional-equities / Nvidia rises after report U.S. cleared Chinese firms to buy H200 chips
Nvidia rises after report U.S. cleared Chinese firms to buy H200 chips
May 14, 2026 · Source: investing.com · Topic:
institutional-equities · insurance-and-insurtech · geopolitical-risk-supply-chain
Approved Chinese Companies
10
Number of Chinese firms approved to purchase H200 chips
Chips Per Buyer
75,000
Maximum number of chips each approved buyer can purchase from Nvidia
China's Revenue Share
13%
Percentage of Nvidia's revenue that comes from China
⦿ Executive Snapshot
- What: Nvidia's shares rose following reports that the U.S. has cleared several Chinese firms to purchase H200 AI chips.
- Who: Nvidia, Chinese companies including Alibaba, Tencent, ByteDance, and JD.com, U.S. Commerce Department, President Donald Trump.
- Why it matters: This event marks a potential thawing in U.S.-China tech relations and could significantly impact Nvidia's sales and market position in China, which has been critical for its revenue.
⦿ Key Developments
- The U.S. has approved approximately 10 Chinese companies to purchase H200 chips, including major firms like Alibaba and Tencent.
- Each approved buyer can purchase up to 75,000 chips directly from Nvidia or through approved distributors like Lenovo and Foxconn.
- Nvidia's CEO Jensen Huang is on a significant visit to China aimed at reviving sales, following an invitation from President Trump.
⦿ Strategic Context
- Prior to tightened U.S. export restrictions, Nvidia held around 95% of China’s advanced chip market, with China accounting for 13% of the company's revenue.
- The backdrop of U.S.-China relations is critical, as tensions have previously led to significant market shifts and impacts on tech exports.
⦿ Strategic Implications
- Immediate market implications include potential sales recovery for Nvidia, which could strengthen its competitive position against other semiconductor firms.
- Long-term implications involve the ongoing dynamics of U.S.-China trade relations and how these approvals may signal a more cooperative approach to tech exports.
⦿ Risks & Constraints
- Potential regulatory risks exist in China, where government guidance could lead to scrutiny or blocking of orders from these approved companies.
- Competition from other semiconductor firms may intensify as the market dynamics shift with renewed access to Chinese buyers.
⦿ Watchlist / Forward Signals
- Future developments to watch include the timeline for actual chip deliveries and any changes in U.S. export policy regarding technology to China.
- The success or failure of these sales will be indicated by the volume of orders placed by the approved firms in the coming months.
§ 08
Related Articles
Experian bolsters verification capabilities with Konfir acquisition
§ 01 Executive Snapshot What: Experian has acquired Konfir to enhance its verification capabilities.
fintechfutures.com
Zealand Pharma Announces Financial Results for the First Half of 2026
§ 01 Executive Snapshot What: Zealand Pharma announced its financial results for the first half of 2
google.com
Volatus Aerospace Releases Q2 2026 Financial Results
§ 01 Executive Snapshot What: Volatus Aerospace released its financial results for Q2 2026, showcasi
google.com
Outlook Therapeutics Reports Third Quarter Fiscal Year 2026
§ 01 Executive Snapshot What: Outlook Therapeutics reported its third quarter fiscal results for 202
google.com